title: Recurrent atrial fibrillation associated with pulse administration of high doses of methylprednysolone: a possible prophylactic treatment.
authors.forename: R
authors.initials: R
authors.lastname: Moretti
authors.forename: P
authors.initials: P
authors.lastname: Torre
authors.forename: R M
authors.initials: RM
authors.lastname: Antonello
authors.forename: M
authors.initials: M
authors.lastname: Zorzon
authors.forename: G
authors.initials: G
authors.lastname: Cazzato
mesh_terms: D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use; D001281:Atrial Fibrillation / Q000175:diagnosis / Q000209:etiology* / Q000517:prevention & control*; D004077:Digoxin / Q000627:therapeutic use; D004562:Electrocardiography; D006801:Humans; D008297:Male; D008775:Methylprednisolone / Q000008:administration & dosage*; D008875:Middle Aged; D020528:Multiple Sclerosis, Chronic Progressive / Q000188:drug therapy; D011405:Propafenone / Q000627:therapeutic use; D020551:Pulse Therapy, Drug / Q000009:adverse effects*; D016896:Treatment Outcome
chemical_list: D000889:Anti-Arrhythmia Agents; D011405:Propafenone; D004077:Digoxin; D008775:Methylprednisolone